维普中文期刊产品整合服务
10篇 您的检索式:作者名="Thomas Pappas"
    题名 作者 年代 出处 被引量
1Prevalence of hepatitis B and C markers among refugees in Athens显示文摘AIM: To assess the prevalence of hepatitis B and C serological markers in a population of refugees living in Athens.METHODS: One hundred and thirty refugees (81 males and 49 females, mean age ±SD: 31.7±8 years) were included in the study. The hepatitis B virus surface antigen (HBsAg),the hepatitis B virus core antibody (anti-HBc) and the hepatitis C virus antibody (anti-HCV) were detected using a third-generation immunoassay.RESULTS: Twenty individuals (15.4%) were HBsAg positive and 69 (53.1%) were anti-HBc positive. The prevalence of HBsAg and anti-HBc was higher among refugees from Albania and Asia (statistical significant difference, P<0.008 and P<0.001 respectively). The prevalence of these markers was found irrelevant to age or sex. Anti-HCV was detected in the serum of 3 individuals (2.3 %). No differences among age, sex or ethnicity regarding anti-HCV prevalence were found.CONCLUSION: It can be concluded that refugees living in Athens are an immigrant population characterized by a high incidence of HBV infection. The prevalence of HBV markers is higher among refugees from Albania and Asia. It is therefore believed that the adherence to general precautions and the initiation of HBV vaccination programs will be necessary in the future, especially in these communities.Although the prevalence of HCV infection seems to be relatively low, extended epidemiological surveys are needed to provide valid results.Anastasios Roussos Constantin Goritsas Thomas Pappas Maria Spanaki Panagiota Papadaki Angeliki Ferti 2003World Journal of Gastroenterology2003,9,5:11
2Reducing Hospital Morbidity and Mortality Following Esophagectomy显示文摘B.Zane Atkins Ashish S. Shah Kelley A. Hutcheson Jennifer H. Mangum Theodore N. Pappas David H. Harpole Thomas A. D’Amico 2004The Annals of Thoracic Surgery2004,,4:2
3Impact of severity of renal dysfunction on determinants of in‐hospital mortality among patients undergoing percutaneous coronary intervention显示文摘Puja B. Parikh Allen Jeremias Srihari S. Naidu Sorin J. Brener Fabio Lima Richard A. Shlofmitz Thomas Pappas Kevin P. Marzo Luis Gruberg 2012Cathet Cardiovasc Intervent2012,,3:1
4Defense mechanisms in inflammatory bowel disease显示文摘Thomas N. Hyphantis John K. Triantafillidis Sofia Pappa Christos Mantas Anna Kaltsouda Peter Cherakakis Yannis Alamanos Orestis N. Manousos Venetsanos G. Mavreas 2005Journal of Gastroenterology2005,,1:1
5Reducing Hospital Morbidity and Mortality Following Esophagectomy显示文摘B.Zane Atkins Ashish S. Shah Kelley A. Hutcheson Jennifer H. Mangum Theodore N. Pappas David H. Harpole Thomas A. D’Amico 2004The Annals of Thoracic Surgery2004,,4:1
6Pathologic Nodal Status Predicts Disease-Free Survival After Neoadjuvant Chemoradiation for Gastroesophageal Junction Carcinoma显示文摘Jeffrey G. Gaca MD Rebecca P. Petersen MD MSc Bercedis L. Peterson PhD David H. Harpole MD Thomas A. D’Amico MD Theodore N. Pappas MD Hilliard F. Seigler MD Walter G. Wolfe MD Douglas S. Tyler MD 2006Annals of Surgical Oncology2006,,3:1
7Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment显示文摘Chrisavgi Pappa Thomas Hyphantis Sofia Pappa Miltiadis Aspiotis Maria Stefaniotou Georgios Kitsos Konstantinos Psilas Venetsanos Mavreas 2006Journal of Psychosomatic Research2006,,5:1
8In-Vacuum Photogrammetry of a 10-Meter Solar Sail显示文摘Chris G Meyer Thomas W Jones Charles B Lunsford Richard S Pappa 2005American Institue of Aeronauticsand Astronautics2005,,:1
9Early thrombus removal strategies for acute deep venous thrombosis: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum显示文摘Mark H. Meissner Peter Gloviczki Anthony J. Comerota Michael C. Dalsing Bo G. Eklof David L. Gillespie Joann M. Lohr Robert B. McLafferty M. Hassan Murad Frank Padberg Peter Pappas Joseph D. Raffetto Thomas W. Wakefield 2012Journal of Vascular Surgery2012,,5:1
10Factors associated with success of telaprevir-and boceprevir-based triple therapy for hepatitis C virus infection显示文摘AIM To evaluate new therapies for hepatitis C virus(HCV), data about real-world outcomes are needed.METHODS Outcomes of 223 patients with genotype 1 HCV who started telaprevir-or boceprevir-based triple therapy(May 2011-March 2012) at the Mount Sinai Medical Center were analyzed. Human immunodeficiency viruspositive patients and patients who received a liver transplant were excluded. Factors associated with sustained virological response(SVR24) and relapse were analyzed by univariable and multivariable logistic regression as well as classification and regression trees. Fast virological response(FVR) was defined as undetectable HCV RNA at week-4(telaprevir) or week-8(boceprevir). RESULTS The median age was 57 years, 18% were black, 44% had advanced fibrosis/cirrhosis(FIB-4 ≥ 3.25). Only 42%(94/223) of patients achieved SVR24 on an intention-totreat basis. In a model that included platelets, SVR24 was associated with white race [odds ratio(OR) = 5.92, 95% confidence interval(CI): 2.34-14.96], HCV sub-genotype 1b(OR = 2.81, 95%CI: 1.45-5.44), platelet count(OR = 1.10, per x 104 cells/μL, 95%CI: 1.05-1.16), and IL28 B CC genotype(OR = 3.54, 95%CI: 1.19-10.53). Platelet counts > 135 x 103/μL were the strongest predictor of SVR by classification and regression tree. Relapse occurred in 25%(27/104) of patients with an end-oftreatment response and was associated with non-FVR(OR = 4.77, 95%CI: 1.68-13.56), HCV sub-genotype 1a(OR = 5.20; 95%CI: 1.40-18.97), and FIB-4 ≥ 3.25(OR = 2.77; 95%CI: 1.07-7.22). CONCLUSION The SVR rate was 42% with telaprevir-or boceprevirbased triple therapy in real-world practice. Low platelets and advanced fibrosis were associated with treatment failure and relapse.Kian Bichoupan Neeta Tandon Valerie Martel-Laferriere Neal M Patel David Sachs Michel Ng Emily A Schonfeld Alexis Pappas James Crismale Alicia Stivala Viktoriya Khaitova Donald Gardenier Michael Linderman William Olson Ponni V Perumalswami Thomas D Schiano Joseph A Odin Lawrence U Liu Douglas T Dieterich Andrea D Branch 2017World Journal of Hepatology2017,9,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费